Back

Itaconate reduces mitochondrial respiratory threshold and improves both inotropy and lusitropy in human hypertrophic myocardium

31 August 2026 (13:15 - 13:35)
Organised by: Logo
Congress Presentation Part of: Cardiac remodelling, fibrosis, and heart failure Mitochondria ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yann Huey Ng

University of Sydney, Sydney (Australia)

2 More presentations in this session

Presentation thumbnail
The antifibrotic effect of empagliflozin: Insights from the EMPIRE trial programme
Doctor J. Jensen (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
PARP1 mediates the PI3K/AKT signaling pathway through PARylation-dependent to alleviate the myocardial injury caused by Cediranib
Mr X. Ma (Lanzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiac remodelling, fibrosis, and heart failure

The Event

Event poster

ESC Congress 2026

31 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiac macrophages maintain myocardial function and contractility in human heart failure
31 August 2025
thumbnail
Congress Presentation
Ketone treatment has favourable effects on cardiac energy metabolism in patients with chronic heart failure
30 August 2026
thumbnail
Congress Presentation
Plasma metabolome reveals systemic oxidative stress and impaired mitochondrial energetics in coronary microvascular dysfunction
30 August 2026
thumbnail
Congress Session
What the heart eats matters: metabolism and cardiovascular disease
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources